These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2857060)

  • 41. Haemodynamic effects of prenalterol in patients on dialysis.
    Lustenberger N
    Acta Med Scand Suppl; 1982; 659():157-67. PubMed ID: 6127886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute haemodynamic effects of oral prenalterol in severe heart failure.
    Petch MC; Wisbey C; Ormerod O; Scott C; Goodfellow RM
    Br Heart J; 1984 Jul; 52(1):49-52. PubMed ID: 6146324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrophysiological effects of prenalterol on the cardiac conduction system.
    Dahlström U; Lassvik C
    Eur Heart J; 1983 Oct; 4(10):728-32. PubMed ID: 6653583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 45. [2 case reports. The use of prenalterol as an antidote to massive overdosage with beta blockaders].
    Kulling P; Eleborg L; Persson H
    Lakartidningen; 1982 Feb; 79(7):518-20. PubMed ID: 6123634
    [No Abstract]   [Full Text] [Related]  

  • 46. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
    Reiz S; Friedman A; Häggmark S
    Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic effects of prenalterol in healthy volunteers.
    Klein G; Wirtzfeld A; Schmidt G; Zilker T
    Acta Med Scand Suppl; 1982; 659():137-46. PubMed ID: 6127884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
    [No Abstract]   [Full Text] [Related]  

  • 49. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
    Dahlström U; Areskog M; Wranne B; Karlsson E
    Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of prenalterol on orthostatic hypotension in the Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Fagard R; Knockaert D
    Br Med J (Clin Res Ed); 1984 Mar; 288(6420):817-8. PubMed ID: 6142747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of heart failure with beta adrenoceptor agonists].
    Klein G; Wirtzfeld A; Schnelle K
    MMW Munch Med Wochenschr; 1983 Apr; 125(14):277-80. PubMed ID: 6134232
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.
    Lambertz H; Meyer J; Erbel R
    Circulation; 1984 Feb; 69(2):298-305. PubMed ID: 6140091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1169-74. PubMed ID: 2869574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardioselectivity of prenalterol and isoproterenol.
    Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
    Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Recently registered drugs].
    Harvengt C
    Acta Clin Belg; 1982; 37(5):325-7. PubMed ID: 6130659
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failure.
    Dahlström U; Graffner C; Jonsson U; Hoffmann KJ; Karlsson E; Lagerström PO
    Eur J Clin Pharmacol; 1983; 24(4):495-502. PubMed ID: 6861864
    [No Abstract]   [Full Text] [Related]  

  • 59. Urological aspects of the Shy-Drager syndrome: a urodynamic and telemetric investigation. Incontinence treatment by electrical pacemaker and prenalterol.
    Vereecken RL; Goovaerts J; Knockaert D; Joossens J; Sansen W
    Eur Urol; 1985; 11(1):65-8. PubMed ID: 2859197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
    Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
    Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.